Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s footer “Revision” indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check19 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a related topic for Marinesco-Sjögren syndrome. Included a resources section linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded Revision v3.5.0 and removed Revision v3.4.3.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. The update appears to concern site versioning rather than the study details.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision: v3.4.2 has been added. The previous funding-status notice and Revision: v3.4.1 have been removed.SummaryDifference0.4%

Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.